Figure 2.

Expression of GPER/GPR30 in mouse lung tumors. (A) IHC analyses of mouse lung cancer (induced with MCA-BHT). The whole lungs were stained with H & E (A), GPR30 C-terminal antibody (Novus Biologicals, 10 μg/ml) (B) along with isotype control (C) and PCNA (D) using standard IHC protocols.

Jala et al. BMC Cancer 2012 12:624   doi:10.1186/1471-2407-12-624
Download authors' original image